Bill Snyder

February 6, 2020

Antibody mixture may help block Ebola virus infection

A research team led by scientists at Vanderbilt University Medical Center has developed an antibody mixture that in animals is highly effective in blocking infection by the Ebola virus.

By Bill Snyder
February 6, 2020

Conn, Calipari to receive major pharmacology awards

Two Vanderbilt University pharmacologists have won prestigious awards from the American Society for Pharmacology and Experimental Therapeutics (ASPET).

By Bill Snyder
February 6, 2020

Carnahan named associate director of Vaccine Center

Robert Carnahan, PhD, associate professor of Pediatrics and Radiology and Radiological Sciences, has been appointed associate director of the Vanderbilt Vaccine Center.

By Bill Snyder
February 6, 2020

Genetics and EHRs

Lisa Bastarache, MS, research assistant professor of Biomedical Informatics, and Tony Capra, PhD, associate professor of Biological Sciences and Biomedical Informatics, described the intersection of genetics and electronic health records during last week’s Cutting-Edge Discovery Lecture.

By Bill Snyder
February 6, 2020

Team tracks integrin’s role in lung function

Beta-1 integrin, a critical component of epithelial extracellular matrix receptors, is essential for normal lung function in adulthood, researchers at VUMC have discovered.

By Bill Snyder
February 6, 2020

Nobel Prize-winning biochemist Stanley Cohen dies at 97

Vanderbilt University biochemist Stanley Cohen, PhD, whose discovery of epidermal growth factor (EGF) and its receptor earned him a Nobel Prize and opened the door to a new class of cancer therapies, died Wednesday, Feb. 5, in Nashville. He was 97.

By Bill Snyder
February 5, 2020

Vaccine Program receives NIH renewal of VTEU

The Vanderbilt Vaccine Research Program has received a grant from the NIH to continue its work as one of the nation’s nine Vaccine and Treatment Evaluation Units.
By Bill Snyder
January 29, 2020

Protein research seeks to induce tumor regression

Understanding how MYC interacts with WDR5 and other cofactors could lead to the development of new drugs that can effectively block MYC and stop many cancers in their tracks.
By Bill Snyder
January 23, 2020

Vaccine Program receives NIH renewal of VTEU

The Vanderbilt Vaccine Research Program (VVRP) has received a grant from the National Institutes of Health (NIH) to continue its work as one of the nation’s nine Vaccine and Treatment Evaluation Units (VTEUs).
By Bill Snyder
January 23, 2020

Antibody isolated at VUMC found to halt dengue virus

Using part of an antibody isolated at Vanderbilt that “broadly neutralizes” the human dengue virus, biologists at the University of California San Diego and colleagues have disarmed the mosquito that transmits the disabling and potentially deadly tropical infection.
By Bill Snyder
January 16, 2020

VUMC study sheds light on gastric cancer development

VUMC researchers have created the world’s first laboratory model of precancerous changes in the lining of the stomach, a scientific tour de force that is helping to unlock the mysteries of gastric cancer development.
By Bill Snyder
December 31, 2019

Kavalali receives Humboldt Research Award

Ege T. Kavalali, PhD, professor and acting chair of the Department of Pharmacology in the Vanderbilt University School of Medicine, has been elected a recipient of a prestigious Humboldt Research Award by the Alexander von Humboldt Foundation of Germany.
By Bill Snyder
1 … 46 47 48 49 50 … 116